 Douglas is president and CEO of THEVAX Genetics Vaccine USA and is president emeritus of Austen BioInnovation Institute in Akron, Ohio and senior partner emeritus of Puretech Ventures.He is a member of the Board of Directors of the Battelle Memorial Research Institute, and had been a member of the Board of Trustees at Lehigh University and of the Board of Directors at the Kauffman Foundation, NitroMed, Gene Logic, and Altanos Pharmaceuticals Holding.He had also been a member of the NCATS Scientific Advisory Board of the NIH.